You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

26 Items

Optimal Systemic Therapy for Early Female Breast Cancer

Document Status: In-Review
ID: 1-21

Sep 2014

Organizational Guidance for the Care of Patients with Central Nervous System Tumours in Ontario: Consensus Recommendations

Document Status: Current
ID: GL 9-11

Oct 2024

Pandemic Planning Clinical Guideline for Patients with Cancer

Document Status: Current
Version: 2

Dec 2021

Position Statements for Nursing Practice in Cancer Care

Document Status: Current
Version: 2

May 2021

Recommendations for the Delivery of Psychosocial Oncology Services in Ontario

Document Status: Current

Apr 2018

Single-Agent Interleukin-2 in the Treatment of Metastatic Melanoma

Document Status: Archived
ID: 8-5
Version: 2

Sep 2011

Sunitinib Malate for Gastrointestinal Stromal Tumour (GIST) in Imatinib Mesylate Resistant Patients

Document Status: Archived
ID: 11-8
Version: 2

Oct 2015

Systemic Adjuvant Therapy for Adult Patients at High Risk for Recurrent Melanoma

Document Status: Current
ID: 8-1
Version: 6

Mar 2024

Systemic Therapy for Advanced Gastric and Gastro-Esophageal Carcinoma

Document Status: In-Review
ID: GL 2-26
Version: 3

Aug 2022

Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline

Document Status: In-Review
ID: 3-15
Version: 2

Sep 2014

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Document Status: Current

Updated

Mar 2025

The Role of Trastuzumab (Herceptin) in the Treatment of Women with HER2/neu-overexpressing Metastatic Breast Cancer

Document Status: Archived
ID: 1-15 Version 3
Version: 3

Sep 2011